We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$14.7B
AUM Growth
-$2.91B
Cap. Flow
-$2.63B
Cap. Flow %
-17.88%
Top 10 Hldgs %
6.52%
Holding
4,319
New
695
Increased
988
Reduced
1,077
Closed
1,450

Top Buys

Rank Stock Value
1
GM icon
General Motors
GM
+$66.2M
2
WFC icon
Wells Fargo
WFC
+$57M
3
SNOW icon
Snowflake
SNOW
+$53.6M
4
TMO icon
Thermo Fisher Scientific
TMO
+$52.1M
5
AVGO icon
Broadcom
AVGO
+$43.5M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$76.6M
2
ZTS icon
Zoetis
ZTS
+$67.5M
3
UBER icon
Uber
UBER
+$57.3M
4
MMM icon
3M
MMM
+$53.2M
5
NFLX icon
Netflix
NFLX
+$52.5M

Sector Composition

Rank Sector Weight
1 Technology 7.73%
2 Industrials 6.11%
3 Consumer Discretionary 5.41%
4 Financials 4.9%
5 Healthcare 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBKR icon
3451
Interactive Brokers
IBKR
$41.1B
-244,664
Closed -$7.3M
IBN icon
3452
ICICI Bank
IBN
$108B
-117,361
Closed -$3.1M
IBP icon
3453
Installed Building Products
IBP
$6.27B
-2,456
Closed -$553K
IBRX icon
3454
ImmunityBio
IBRX
$7.94B
-56,968
Closed -$306K
ICE icon
3455
Intercontinental Exchange
ICE
$84.5B
-51,468
Closed -$7.07M
ICUI icon
3456
ICU Medical
ICUI
$4.56B
-21,008
Closed -$2.21M
ICUI icon
3457
PUT
ICU Medical
ICUI
$4.56B
-14,500
Closed -$1.56M
IDCC icon
3458
InterDigital
IDCC
$8.99B
-90,213
Closed -$9.6M
IDYA icon
3459
IDEAYA Biosciences
IDYA
$3.54B
-15,237
Closed -$669K
IDXX icon
3460
Idexx Laboratories
IDXX
$46.9B
-21,351
Closed -$10.7M
IFF icon
3461
CALL
International Flavors & Fragrances
IFF
$21.7B
-2,900
Closed -$249K
IMAX icon
3462
IMAX
IMAX
$2.81B
-159
Closed -$2.57K
INBK icon
3463
First Internet Bancorp
INBK
$256M
-3,584
Closed -$125K
INCY icon
3464
Incyte
INCY
$24.6B
-419,241
Closed -$23.9M
INFY icon
3465
Infosys
INFY
$50.9B
-337,477
Closed -$6.05M
ING icon
3466
ING
ING
$101B
-432,642
Closed -$7.13M
INMB icon
3467
INmune Bio
INMB
$58.8M
-4,782
Closed -$56.2K
INMD icon
3468
InMode
INMD
$873M
-127,166
Closed -$2.34M
INSM icon
3469
Insmed
INSM
$29.4B
-67,111
Closed -$2.6M
INTU icon
3470
Intuit
INTU
$91.5B
-5,994
Closed -$3.72M
INVA icon
3471
Innoviva
INVA
$1.49B
-106,849
Closed -$1.63M
INVE icon
3472
Identive
INVE
$61.2M
-20,178
Closed -$160K
IOT icon
3473
Samsara
IOT
$23.2B
-53,033
Closed -$1.83M
IP icon
3474
PUT
International Paper
IP
$21.9B
-15,500
Closed -$605K
IPAR icon
3475
Interparfums
IPAR
$3.83B
-16,157
Closed -$2.27M

Similar funds

Cubist Systematic Strategies's Q2 2024 Portfolio in Review

As of Q2 2024, Cubist Systematic Strategies held 4,319 positions worth $14.7B, down 17% from $17.6B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

Cubist Systematic Strategies withdrew a net $2.63B in Q2 2024, closing 1,450 positions and reducing 1,077 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $76.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Cubist Systematic Strategies opened a new position in General Motors worth $68.2M.

  • Cubist Systematic Strategies's largest Q2 2024 buy was General Motors: 1,467,209 shares worth $68.2M.
  • Cubist Systematic Strategies added most to Thermo Fisher Scientific in Q2 2024, an estimated $52.1M increase.
  • Cubist Systematic Strategies's biggest Q2 2024 reduction was Uber, cutting an estimated $57.3M.
  • Cubist Systematic Strategies fully exited Meta Platforms (Facebook) in Q2 2024, selling an estimated $76.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 6.5% of its $14.7B portfolio in Q2 2024.
  • Cubist Systematic Strategies opened 695 new positions and closed 1,450 in Q2 2024.
  • Cubist Systematic Strategies's portfolio value fell 17% quarter-over-quarter to $14.7B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.